Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor mediates inflammation.

Arthur J Chu1

  • 1MRC, Shantou University, Shantou, Guangdong 515063, PR China. ajchu91@hotmail.com

Archives of Biochemistry and Biophysics
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits.

Frontiers in bioscience (Landmark edition)·2022
Same author

Antagonism by bioactive polyphenols against inflammation: a systematic view.

Inflammation & allergy drug targets·2013
Same author

Tissue factor, blood coagulation, and beyond: an overview.

International journal of inflammation·2011
Same author

Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.

Inflammation & allergy drug targets·2010
Same author

Blood coagulation as an intrinsic pathway for proinflammation: a mini review.

Inflammation & allergy drug targets·2009
Same author

Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.

Frontiers in bioscience : a journal and virtual library·2005

Tissue factor (TF) drives inflammation through blood coagulation, activating signaling cascades that promote inflammatory responses. Targeting TF, anticoagulation, or protease-activated receptors (PARs) can disrupt this cycle for anti-inflammatory and anti-thrombotic benefits.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Biology

Background:

  • Tissue factor (TF) is a key initiator of the extrinsic blood coagulation cascade.
  • TF upregulation is linked to both hypercoagulable and inflammatory states.
  • Coagulant mediators like FVIIa, FXa, and thrombin (FIIa) are proinflammatory.

Purpose of the Study:

  • To elucidate the role of tissue factor in mediating inflammation via blood coagulation.
  • To explore the signaling pathways involved in coagulation-induced inflammation, particularly through protease-activated receptors (PARs).
  • To identify potential therapeutic strategies for interrupting the coagulation-inflammation cycle.

Main Methods:

  • The study reviews the mechanisms by which TF initiates coagulation and triggers inflammatory responses.

Related Experiment Videos

  • It examines the role of serine proteases (FVIIa, FXa, FIIa) and fibrin in promoting inflammation via PARs.
  • It discusses antagonism strategies including TF downregulation, anticoagulation, and PAR blockade.

    • Main Results:

    • TF initiates coagulation cascades involving FVIIa, FXa, and FIIa, leading to fibrin clot production.
    • Proinflammatory mediators generated during coagulation activate PARs, inducing inflammatory responses.
    • Fibrin and its fragments also contribute to inflammation.
    • TF hypercoagulability exacerbates inflammation due to elevated clotting signals.

    Conclusions:

    • TF-mediated coagulation is a significant driver of inflammation.
    • Coagulant mediators and fibrin act as proinflammatory signals.
    • Therapeutic strategies targeting TF, anticoagulation, or PARs can interrupt the coagulation-inflammation cycle.
    • These approaches offer potential for both anti-inflammatory and anti-thrombotic effects, including cardioprotection.